Neuroimaging plays a pivotal role in understanding Alzheimer’s Disease and dementia by providing non-invasive methods to visualize brain structure and function. Techniques like MRI (Magnetic Resonance Imaging) reveal structural changes such as brain atrophy, a hallmark of Alzheimer’s. Functional MRI (fMRI) helps study brain activity patterns, highlighting areas affected by dementia-related cognitive decline. PET (Positron Emission Tomography) scans detect amyloid plaques and tau tangles, key pathological features in Alzheimer’s. These imaging tools aid in early diagnosis, tracking disease progression, and assessing treatment effectiveness. Advances in neuroimaging continue to refine our understanding of how Alzheimer’s alters the brain, offering hope for improved diagnostic accuracy and targeted therapeutic strategies.
Title : Make a difference
Jacqueline Tuppen, Dementia UK, United Kingdom
Title : Imaging brain clearance in Alzheimer’s disease
Jun Hua, Johns Hopkins University , United States
Title : Association between APOE allele prevalence and Alzheimer's disease risk in Southwestern Uganda
Frank Balikoowa, African Research Center for Ageing & Dementia, Uganda
Title : Healthcare professionals in Somaliland had low levels of knowledge and attitudes towards dementia care: A pilot survey
Mohamed Abdilahi Duale, Frantz Fanon University, Somalia
Title : Association between depressive symptoms and cognitive impairment severity in a real-world memory clinic cohort
Yun Ju Hsieh, Taipei City Hospital, Taiwan
Title : Neuromodulation of scalp electroacupuncture in the treatment of autism spectrum disorder
Zhenhuan Liu, Nanhai Maternity and Children Hospital Affiliated to Guangzhou University of Chinese Medicine, China